<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> in adults (LADA) is a subgroup of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, which procession of autoimmune destruction of beta-cells was slower than classic type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate the pathogenesis of LADA, we examined the lymphocyte subsets including the CD4(+)CD25(+) T-cells in 60 LADA patients and 30 patients of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and 30 healthy individuals by FACS </plain></SENT>
<SENT sid="2" pm="."><plain>And we compared the expression of FOXP3 <z:chebi fb="2" ids="33699">mRNA</z:chebi> in CD4(+) T-cell between 10 patients of LADA and 10 matched healthy individuals by real time PCR </plain></SENT>
<SENT sid="3" pm="."><plain>The percent of CD4(+)CD25(+) T-cells were higher (11.89+/-4.96% versus 8.16+/-3.65%, P&lt;0.01), and the percent CD8(+) T-cells elevated (24.58+/-6.80% versus 19.39+/-7.12, P&lt;0.01) in LADA patients than healthy individuals </plain></SENT>
<SENT sid="4" pm="."><plain>While the expression of FOXP3 <z:chebi fb="2" ids="33699">mRNA</z:chebi> in CD4(+) T-cell was markedly decreased in LADA patients (0.52-fold, n=10, P=0.004) compared with <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, the percent of CD8(+) T-cells related with GAD-Ab titers in LADA patients (r=0.292, P=0.03) </plain></SENT>
<SENT sid="6" pm="."><plain>Our results showed that there were cellular <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune disorder</z:e> and decreased CD4(+) regulatory T-cells in LADA patients </plain></SENT>
<SENT sid="7" pm="."><plain>The adoptive transfer regulatory T-cells seem to be a potential therapeutics for LADA </plain></SENT>
</text></document>